Global Peptide Therapeutics Market
Pharmaceuticals

Peptide Therapeutics Market Forecast Reaching $76.64 Billion by 2029 at 11% CAGR

Discover trends, market shifts, and competitive outlooks for the peptide therapeutics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Has the Peptide Therapeutics Market Growth Performance Trended Historically, And What Lies Ahead?#_x000D_

The size of the peptide therapeutics market has expanded swiftly in the past few years. The market is expected to rise from $45.15 billion in 2024 to $49.67 billion in 2025, with a compound annual growth rate (CAGR) of 10.0%. The surge in the historic period can be linked to a rise in chronic diseases, enhanced knowledge of molecular biology, and broadened applications in oncology._x000D_

_x000D_

The market for peptide therapeutics is predicted to experience a swift expansion in the coming years, having a projected value of $76.64 billion in 2029, with a compound annual growth rate (CAGR) of 11.5%. Factors driving growth during the forecast period include the increasing need for personalized medicine, widespread application in immunotherapy, advancements in peptide delivery systems, burgeoning peptide targets in infectious disease treatment, and an intensified focus on rare diseases. The forecast period is also likely to see noteworthy trends such as technological progress in peptide synthesis, an upsurge in investments and funding, heightened attention to peptide drug safety, market growth in emerging economies, backed by the integration of artificial intelligence (AI)._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=7216&type=smp_x000D_

_x000D_

#Which Major Market Drivers Are Expected to Boost the Growth Potential of the Peptide Therapeutics Market?#_x000D_

The expected surge in chronic diseases is projected to drive the growth of the peptide therapeutics market. Chronic diseases refer to long-term illnesses that are often incurable but can occasionally be treated and managed. The rise in chronic diseases can be attributed to increased tobacco usage, inadequate nutrition, lack of physical activity, and excessive alcohol consumption, among other factors. Peptide therapeutics is utilized in the prevention and control of certain chronic diseases. For example, the National Library of Medicine, a US based entity, projected in January 2023 that the number of individuals above the age of 50 in the US with at least one chronic condition will escalate by 99.5%, reaching 142.66 million by 2050. Thus, the surge in chronic diseases is anticipated to fuel the peptide therapeutics market across the forecast timeframe._x000D_

_x000D_

#Which Key Market Segments Comprise the Peptide Therapeutics Market and Drive Its Revenue Growth?#_x000D_

The peptide therapeutics market covered in this report is segmented –_x000D_

_x000D_

1) By Type: Generic, Branded_x000D_

2) By Route of Administration: Parenteral, Mucosal, Oral, Transdermal_x000D_

3) By Application: Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications_x000D_

_x000D_

Subsegments:_x000D_

1) By Generic: Generic Peptide Drugs, Biosimilars_x000D_

2) By Branded: Innovative Peptide Drugs, Patent-Protected Peptides_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=7216&type=smp_x000D_

_x000D_

#Which Areas Are Leading Regions in the Peptide Therapeutics Market Expansion Across the Globe?#_x000D_

North America was the largest region in the peptide therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Are the Key Market Trends in thePeptide Therapeutics Market Over the Coming Years?#_x000D_

Large corporations in the peptide therapeutics market are concentrating on developing innovative solutions like the cell culture process to maintain their market dominance. This process involves nurturing cells outside their natural habitats under carefully controlled conditions, necessitating the extraction of intended cells from living tissue and their subsequent preservation. For example, in June 2023, Evonik Industries AG, a specialty chemicals company based in Germany, introduced cQrex KC. Designed for biopharma applications, cQrex KC is a state-of-the-art peptide for the cell culture process deployed in the production of biological drugs. This innovation assists developers in refining cystine supply and augmenting cell culture productivity. Furthermore, cQrex KC contributes to the advancement of vaccines, viral vectors, and cell therapies._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report_x000D_

_x000D_

#How Is the Peptide Therapeutics Market Conceptually Defined?#_x000D_

Peptide therapeutics refer to a therapeutic approach that uses peptides as medications. Peptides are a distinct family of pharmacological substances that are molecularly situated in between proteins and tiny molecules. Peptides that are found in nature serve a variety of purposes, including those of hormones, growth factors, neurotransmitters, ion channel ligands, and anti-infectives. Consequently, using peptides as treatments offers a way to target a variety of cells and control their response._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7216_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model